Received Jul 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | UNK | X10141M | OT |
received two doses of IPOL with no reported adverse event; Initial information received on 03-Jul-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age and gender patient who received two doses of IPV (VERO) [IPOL] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received two doses of IPV (VERO) Suspension for injection (strength- unknown, expiry date- 03-Oct-2026 and lot X10141M) via unknown route in unknown administration site for Immunization with no reported adverse event (extra dose administered) (same day latency). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.